ZURA BIO LIMITED
(NASDAQ: ZURA)

Zura Bio Ltd. is a clinical-stage biotechnology company that engages in the development of novel medicines for immune disorders. It focuses on the development of ZB-168, a treatment for Alopecia Areata and other inflammatory diseases. The company was founded in January 2022 and is headquartered in La Jolla, CA.

5.190

+0.030 (+0.58%)
Range - - -   (-%)
Open -
Previous Close 5.160
Bid Price 5.320
Bid Volume 8
Ask Price 5.390
Ask Volume 9
Volume 128,198
Value -
Remark
Delayed prices. Updated at 16 May 2024 03:59.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis